Could a simple gel prevent bleeding after tonsil surgery?

NCT ID NCT07060495

Recruiting now Symptom relief Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests a special gel called RADA-16 that is applied to the throat after tonsil removal. The goal is to see if it reduces bleeding and pain compared to standard care. About 134 adults having tonsillectomy will take part and report their symptoms via online surveys for 15 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RADA-16 hydrogel (a self-assembling peptide gel applied to the surgical site)
What this could lead to: If it works, this gel could reduce painful bleeding after tonsillectomy, making recovery easier and safer.
What could go wrong: This is a relatively small Phase 3 trial, and the gel may not significantly reduce bleeding or pain compared to standard care. Risks include allergic reaction or infection at the site.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PAIN

Contacts and locations

Locations

Cooperman Barnabas Medical Center
RECRUITING

Livingston, New Jersey, 07039, United States
University Hospital
NOT_YET_RECRUITING

Newark, New Jersey, 07103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.